Tela Bio (NASDAQ:TELA) is a company that specializes in developing and marketing a broad range of innovative, cost-effective, and biologically enhanced soft tissue repair solutions designed to address the needs of patients, surgeons, and healthcare systems worldwide. Its portfolio mainly focuses on the reinforcement of soft tissue repairs in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. Utilizing its proprietary "OviTex" technology, Tela Bio aims to advance the clinical outcomes in soft tissue repair while reducing overall healthcare costs. The company's commitment is towards improving patient care and outcomes through the integration of biologic and synthetic materials. Tela Bio is dedicated to innovation, excellence, and the ongoing development of technologies that meet the evolving demands of the surgical community.